1. A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer. (April 2016) Authors: Suker, M.; Sadot, E.; Marthey, L.; Moorcraft, S.Y.; Conroy, T.; El-Rayes, B.; Faris, J.; Lacy, J.; Mellon, E.A.; van Eijck, C.H.J.; Groot Koerkamp, B. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intratumoral interleukin-6 and myeloid cell subsets within the cholangiocarcinoma tumor microenvironment. (March 2019) Authors: Zaidi, M.Y.; Ware, M.B.; Krasinskas, A.; Farren, M.R.; Li, Y.; Chen, Z.; Elnaggar, O.; Che, Z.; El-Rayes, B.; Maithel, S.K.; Lesinski, G.B. Journal: HPB Issue: Volume 21(2019)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis. (2020) Authors: Buettner, S.; Janssen, Q.; Suker, M.; Beumer, B.; Addeo, P.; Bachellier, P.; Bahary, N.; Bekaii-Saab, T.; Bali, M.; Besselink, M.; Boone, B.; Chau, I.; Clarke, S.; Dillhoff, M.; El-Rayes, B.; Frakes, J.; Grose, D.; Hosein, P.; Jamieson, N.; Javed, A. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗